Clinical TrialsSearch results
Number of results: 220
Not yet recruiting
- A validation study of the cognitive assessment program (VR-E)
- cognitively healthy subjects and subjects with dementia or mild cognitive impairment (MCI)
- Kamimura Masumi
- 2025-02-12
Recruiting
- [M24-697] A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of OnabotulinumtoxinA Purified Neurotoxin Complex for the Treatment of Moderate to Severe Forehead Lines in Japan
- Forehead Lines
- Yajima Yoko
- 2025-01-28
Recruiting
- [M25-145] A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Upadacitinib in Combination with Topical Corticosteroids in Children from 2 to Less than 12 Years of Age in Japan with Moderate to Severe Atopic Dermatitis
- Atopic Dermatitis
- Fujimura Kimino
- 2024-12-10
Recruiting
- Depressive Episodes Associated with Bipolar I or II Disorder: A Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of ABBV-932
- Bipolar I Disorder Bipolar II Disorder
- Otani Tetsuya
- 2024-11-12
Recruiting
- Follow-up study
- Bladder cancer
- Fukuhara Hideo
- 2024-10-30
Recruiting
- A study to test different doses of BI 1569912 in people with depression
- Major Depressive Disorder
- Taguchi Aya
- 2024-10-03
Recruiting
- A study to evaluate the efficacy and safety of subcutaneous amlitelimab monotherapy compared with placebo in adult participants with severe alopecia areata
- Alopecia areata
- Tanaka Tomoyuki
- 2024-07-07
Recruiting
- A study to evaluate the treatment response and safety of two dose regimens of subcutaneous amlitelimab monotherapy compared with treatment withdrawal in participants aged 12 years and older with moderate-to-severe atopic dermatitis
- Dermatitis atopic
- Tanaka Tomoyuki
- 2024-06-28
Recruiting
- Atopic Dermatitis: A Study of Upadacitinib in Adult Subjects with Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab (SWITCH-UP)
- Atopic Dermatitis
- Otani Tetsuya
- 2024-06-21
Recruiting
- A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo
- NonSegmental Vitiligo
- Ono Shintaro
- 2024-06-14